This activity is no longer available for credit, however its content is still (may still be) relevant for your educational needs.
Valid: October 17th, 2008 - October 17th, 2009
This activity is no longer available for credit, however its content is still relevant for your educational needs.
This activity was developed for physicians, physician assistants, nurses, pharmacists, and other healthcare stakeholders who wish to enhance their knowledge concerning recent regulatory changes in the cough/cold market.
At the completion of this activity participants should be able to:
- Describe significant points of the US Food and Drug Administrationâ€™s rationale for removing nonapproved hydrocodone containing cough suppressants from the market.
- List cough suppressants containing hydrocodone that remain available today and discuss the appropriate use of these products.
- Identify and discuss patient education strategies to reinforce the safe and effective use of these products.
The information provided in this CME/CE activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patientâ€™s medical condition.
Melvin Pratter, MD is on the speaker's bureau for Boehringer Ingelheim, Merck, and Pfizer, and is a consultant for Venture Capital Firm.
Bart Feldman, BS, BSPharm has nothing to disclose.
Mary Knudtson, DNSc, NP has nothing to disclose.
Gary M. Owens, MD, is a Consultant to Asthmatx, Biosense Webster, Centocor-OrthoBiotech, Eli Lilly, Genentech, and Novartis.
*Content will include non-FDA-approved uses.
The content and views presented in this educational activity are those of the authors and do not necessarily reflect those of MER, MLI, or Center of Excellence Media, LLC. The authors have disclosed if there is any discussion of published and/or investigational uses of agents that are not indicated by the FDA in their presentations. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of MER, MLI, Center of Excellence Media, LLC, and sanofi-aventis. Before prescribing any medicine, primary references and full prescribing information should be consulted. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patientâ€™s conditions and possible contraindications on dangers in use, review of any applicable manufacturerâ€™s product information, and comparison with recommendations of other authorities. The information presented in this activity is not meant to serve as a guideline for patient management.